|
業務類別
|
Biotechnology |
|
業務概覽
|
SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company focused on developing multi-specific, high-potency, human immunoglobulin G (hIgG) to treat and prevent immune and autoimmune disorders. The company's lead product candidate, SAB-142, targets autoimmune Type 1 Diabetes (T1D) with a disease-modifying therapeutic approach that aims to change the T1D treatment paradigm by delaying onset and potentially preventing disease progression of Stage 3 T1D patients. Itis focused on developing product candidates for disease targets where a differentiated approach has the greatest potential to be either first-in-class against novel targets against complex targets to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders. |
| 公司地址
| 777 West 41st Street, Suite 401, Miami Beach, FL, USA, 33140 |
| 電話號碼
| +1 305 845-2813 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.sab.bio |
| 員工數量
| 86 |
| Dr. Christoph Lawrence Bausch, PhD |
Chief Operating Officer |
美元 412.20K |
09/03/2026 |
| Dr. Eddie J. Sullivan, PhD |
Director and President |
美元 480.90K |
09/03/2026 |
| Mr. Samuel J. Reich |
Director and Chief Executive Officer |
美元 518.30K |
09/03/2026 |
| Dr. Alexandra Kropotova, M.D. |
Chief Medical Officer and Executive Vice President |
美元 540.10K |
09/03/2026 |
| Ms. Lucy To |
Chief Financial Officer and Principal Accounting Officer |
美元 164.40K |
09/03/2026 |
|
|
| Mr. Andrew D. Moin |
Independent Director |
09/03/2026 |
| Admiral Scott Giberson, (Ret.),M.P.H.,R.Ph. |
Independent Director |
09/03/2026 |
| Dr. Eddie J. Sullivan, PhD |
Director and President |
09/03/2026 |
| Mr. David Forrest Link, M.B.A. |
Vice Chairman of the Board |
09/03/2026 |
| Dr. William J. Polvino, M.D. |
Independent Director |
09/03/2026 |
| Ms. Helen Katherine Ellias |
Independent Director |
09/03/2026 |
| Mr. Samuel J. Reich |
Director and Chief Executive Officer |
09/03/2026 |
| Mr. Erick J. Lucera, C.F.A. |
Independent Director |
09/03/2026 |
| Dr. David Zaccardelli, Pharm.D. |
Director |
07/01/2026 |
| Dr. Rita I. Jain, M.D. |
Director |
07/01/2026 |
| Dr. Jay S. Skyler,M.D.,M.A.C.P. |
Independent Director |
09/03/2026 |
|
|
|
|
